EC approves amendment of Valneva’s Covid-19 vaccines purchase deal
The EC member states will now buy 1.25 million doses of VLA2001 this year after amending the previous purchase deal.
Germany
Latest in
Germany
CureVac files patent lawsuit against BioNTech over mRNA technology
The lawsuit was filed against BioNTech and two of its subsidiaries in the German Regional Court in Düsseldorf.
Kinarus’ therapy offers robust antiviral activity against Covid-19 variants
KIN001 acts on the host cell pathways required for the replication of the virus.
Entrance of novel therapies drives alpha-1 antitrypsin deficiency market growth
The alpha-1 antitrypsin deficiency (AATD) market in the US and Germany is expected to see significant growth from 2021 to…
By
BioNTech and Medigene partner to develop immunotherapies for cancer
BioNTech will make an upfront payment of $29.5m to Medigene, which will also receive research funding.
Macro view: Economic growth poised to slow in major economies
The OECD believes that the strong rebound after the Covid-19 economic crisis in 2020 may soon moderate in several major…
BiondVax signs deals to develop nanosized Covid-19 antibodies
Covid-19 NanoAbs demonstrated to have robust competitive advantage against current Covid-19 drugs.
Boehringer Ingelheim and Thoeris to work on urea cycle disorder therapies
Boehringer Ingelheim will contribute its research and drugs development expertise for advancing medications into the clinic.